Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up

Hyperalphalipoproteinemia

MONDO:0015903

An autosomal dominant genetic condition caused by mutation(s) in the CETP gene, encoding cholesteryl ester transfer protein. Affected individuals may have increased longevity due to decreased risk of coronary heart disease.

Also known as: HALP1

11 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Cholesterol-ester transfer protein deficiency (0) Hyperlipidemia due to hepatic triglyceride lipase deficiency (0)

Broader categories

Disease (618) Hyperlipidemia (264) Metabolic disease (215) Human disease (14) Hyperlipoproteinemia (7) Disease by developmental or physiological process (0)
Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1
Sort by
  • New study aims to boost statin use with simple doctor nudges

    Disease control Ongoing

    This study tests two methods to increase referrals to a centralized pharmacy service for managing statin therapy in patients with or at high risk for heart disease. One method sends reminders to doctors during office visits, and the other sends electronic messages outside of visi…

    Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control

    Last updated Jun 27, 2026 12:04 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space